DK0800539T3 - Cyclodekstrinderivater og fremgangsmåder til deres femstilling - Google Patents

Cyclodekstrinderivater og fremgangsmåder til deres femstilling

Info

Publication number
DK0800539T3
DK0800539T3 DK95942008T DK95942008T DK0800539T3 DK 0800539 T3 DK0800539 T3 DK 0800539T3 DK 95942008 T DK95942008 T DK 95942008T DK 95942008 T DK95942008 T DK 95942008T DK 0800539 T3 DK0800539 T3 DK 0800539T3
Authority
DK
Denmark
Prior art keywords
adjuvants
methods
cyclodextrin derivatives
sulpholipid
polysaccharide
Prior art date
Application number
DK95942008T
Other languages
Danish (da)
English (en)
Inventor
Luuk Hilgers
Original Assignee
Dimminaco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3888560&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0800539(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dimminaco Ag filed Critical Dimminaco Ag
Application granted granted Critical
Publication of DK0800539T3 publication Critical patent/DK0800539T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK95942008T 1994-12-27 1995-12-21 Cyclodekstrinderivater og fremgangsmåder til deres femstilling DK0800539T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE9401174A BE1008978A5 (fr) 1994-12-27 1994-12-27 Adjuvants pour vaccins.
PCT/BE1995/000120 WO1996020222A1 (en) 1994-12-27 1995-12-21 Novel cyclodextrin-derivatives and methods for the preparation thereof

Publications (1)

Publication Number Publication Date
DK0800539T3 true DK0800539T3 (da) 2003-12-08

Family

ID=3888560

Family Applications (2)

Application Number Title Priority Date Filing Date
DK95942008T DK0800539T3 (da) 1994-12-27 1995-12-21 Cyclodekstrinderivater og fremgangsmåder til deres femstilling
DK95942007T DK0814836T3 (da) 1994-12-27 1995-12-21 Vaccineadjuvanser

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK95942007T DK0814836T3 (da) 1994-12-27 1995-12-21 Vaccineadjuvanser

Country Status (17)

Country Link
US (2) US6328965B1 (ja)
EP (2) EP0814836B1 (ja)
JP (2) JP3927235B2 (ja)
CN (2) CN1132630C (ja)
AT (2) ATE199644T1 (ja)
AU (2) AU713997B2 (ja)
BE (1) BE1008978A5 (ja)
BR (2) BR9510223A (ja)
CA (2) CA2208849C (ja)
DE (2) DE69520376T2 (ja)
DK (2) DK0800539T3 (ja)
ES (2) ES2204969T3 (ja)
GR (1) GR3035941T3 (ja)
MX (1) MX9704822A (ja)
PT (2) PT800539E (ja)
SI (1) SI0800539T1 (ja)
WO (2) WO1996020222A1 (ja)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1008978A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US5916883A (en) * 1996-11-01 1999-06-29 Poly-Med, Inc. Acylated cyclodextrin derivatives
US6645495B1 (en) * 1997-08-29 2003-11-11 Antigenics, Inc. Compositions of saponin adjuvants and excipients
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
AT408150B (de) * 2000-04-14 2001-09-25 Oesterr Forsch Seibersdorf Verfahren zur immobilisierung eines analyten an einer festen oberfläche
FR2808691B1 (fr) * 2000-05-12 2005-06-24 Coletica Cyclodextrines substituees preferentiellement sur leur face primaire par des fonctions acide ou amine
FR2825714B1 (fr) * 2001-06-08 2005-03-25 Seppic Sa Nouvelle utilisation de complexes d'inclusion de cyclodestrine
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
WO2003086283A2 (en) * 2002-04-09 2003-10-23 Greenville Hospital System Metastasis modulating activity of highly sulfated oligosaccharides
US9050352B2 (en) * 2003-10-16 2015-06-09 Stephen John Ralph Immunomodulating compositions and uses therefor
JP2009517402A (ja) 2005-11-28 2009-04-30 ディー． ロウェ，バーノン 腎毒性の低減に有用な組成物及びその使用方法
US20090017064A1 (en) * 2007-07-10 2009-01-15 Wyeth Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
MX2010005014A (es) * 2007-11-06 2010-06-30 Wyeth Llc Vacuna viva avirulenta de mycoplasma hyopneumoniae con adyuvante.
EP2062594A1 (en) * 2007-11-21 2009-05-27 Wyeth Farma, S.A. Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
US8192721B2 (en) * 2007-12-13 2012-06-05 Verrow Pharmaceuticals, Inc. Compositions useful for reducing toxicity associated with gadolinium-based contrast agents
JP2012530785A (ja) 2009-06-22 2012-12-06 ワイス・エルエルシー 組成物および黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）血清型５および８莢膜多糖コンジュゲート免疫原性組成物を調製するための方法
WO2010151544A1 (en) 2009-06-22 2010-12-29 Wyeth Llc Immunogenic compositions of staphylococcus aureus antigens
US20110110980A1 (en) 2009-09-02 2011-05-12 Wyeth Llc Heterlogous prime-boost immunization regimen
EP2397484A1 (en) 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants
ES2850973T3 (es) 2010-08-23 2021-09-01 Wyeth Llc Formulaciones estables de antígenos rLP2086 de Neisseria meningitidis
WO2012032489A1 (en) 2010-09-10 2012-03-15 Wyeth Llc Non-lipidated variants of neisseria meningitidis orf2086 antigens
CN101972477B (zh) * 2010-10-21 2012-09-26 中国医学科学院医学生物学研究所 磷酸锌疫苗佐剂
DK3150222T3 (da) 2010-12-22 2020-01-27 Wyeth Llc Stabile immunogene sammensætninger af staphylococcus aureus-antigener
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
NZ628449A (en) 2012-03-09 2016-04-29 Pfizer Neisseria meningitidis compositions and methods thereof
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
WO2014097099A2 (en) 2012-12-20 2014-06-26 Pfizer Inc. Glycoconjugation process
JP6446377B2 (ja) 2013-03-08 2018-12-26 ファイザー・インク 免疫原性融合ポリペプチド
CA2923129C (en) 2013-09-08 2020-06-09 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
JP6821429B2 (ja) 2013-09-25 2021-01-27 ゾエティス・サービシーズ・エルエルシー Ｐｃｖ２ｂ分岐ワクチン組成物及び使用方法
CN104013955B (zh) * 2014-06-18 2016-02-24 中国科学院过程工程研究所 一种不含表面活性剂的水包油乳液及其用途
CN104086676B (zh) * 2014-07-18 2017-01-25 江苏省农业科学院 一种环糊精酯化衍生物、制备方法及其应用
CA2954043A1 (en) * 2014-07-24 2016-01-28 Litevax B.V. Carbohydrate ester adjuvants
BR112017017460A2 (pt) 2015-02-19 2018-04-10 Pfizer Inc. composições de neisseria meningitidis e métodos das mesmas
IL297740A (en) 2015-05-04 2022-12-01 Pfizer Protein-polysaccharide conjugates of group b streptococcus, methods for preparing the conjugates, immunogenic preparations containing conjugates and their uses
US10751402B2 (en) 2016-11-09 2020-08-25 Pfizer Inc. Immunogenic compositions and uses thereof
CN110234658B (zh) 2017-01-31 2024-03-12 辉瑞大药厂 脑膜炎奈瑟菌组合物及其使用方法
CN106928378A (zh) * 2017-03-29 2017-07-07 中国药科大学 一种十二酰基‑β‑环糊精的制备方法和用于色氨酸手性拆分的聚砜膜的制备方法
AU2019236328A1 (en) 2018-03-16 2020-09-10 Zoetis Services Llc Peptide vaccines against Interleukin-31
EP4203995A1 (en) 2020-08-26 2023-07-05 Pfizer Inc. Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565887A (en) * 1968-05-15 1971-02-23 Corn Products Co Unsaturated and long chain esters of cyclodextrin
US4247535A (en) * 1979-11-05 1981-01-27 American Cyanamid Company Modified cyclodextrin sulfate salts as complement inhibitors
US5760015A (en) * 1988-01-19 1998-06-02 The Trustees Of The University Of Pennsylvania Cyclodextrin compounds and methods of making and use thereof
US5658894A (en) * 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
EP0518930A4 (en) * 1990-03-02 1993-09-15 Australian Commercial Research & Development Limited Cyclodextrin compositions and methods for pharmaceutical and industrial applications
FR2672496B3 (fr) * 1990-07-18 1993-05-28 Vacsyn France Sa Compositions a base de substances hydrophobes, solubilisables dans un solvant aqueux, leur procede d'obtention, et leurs utilisations notamment dans le domaine pharmaceutique.
US5180716A (en) * 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
IT1242214B (it) * 1990-11-13 1994-03-03 Emo Chiellini Derivati polifunzionali delle ciclodestrine
JP2556236B2 (ja) * 1991-08-29 1996-11-20 田辺製薬株式会社 β−シクロデキストリン誘導体のポリ硫酸エステル及びその製法
ZA929870B (en) * 1991-12-23 1993-08-18 Duphar Int Res Adjuvants
WO1993017711A1 (en) * 1992-03-11 1993-09-16 Australian Commercial Research & Development Limited New cyclodextrins and new formulated drugs
DE4220734A1 (de) * 1992-06-25 1994-01-05 Puetter Medice Chem Pharm Lipophile Cyclodextrinpolymere
US5464827A (en) * 1994-06-20 1995-11-07 American Home Products Corporation Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors
BE1008978A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.

Also Published As

Publication number Publication date
BR9510223A (pt) 1997-12-30
DE69520376T2 (de) 2001-08-09
DE69531699T2 (de) 2004-07-08
DE69520376D1 (de) 2001-04-19
EP0814836A1 (fr) 1998-01-07
US6165995A (en) 2000-12-26
CA2208849A1 (en) 1996-07-04
DK0814836T3 (da) 2001-04-17
ES2204969T3 (es) 2004-05-01
EP0800539A1 (en) 1997-10-15
JPH10511997A (ja) 1998-11-17
JP4087900B2 (ja) 2008-05-21
AU709104B2 (en) 1999-08-19
ES2155540T3 (es) 2001-05-16
ATE199644T1 (de) 2001-03-15
EP0814836B1 (fr) 2001-03-14
AU713997B2 (en) 1999-12-16
CN1132630C (zh) 2003-12-31
CA2208790C (en) 2012-01-31
BR9510263A (pt) 1997-11-04
CA2208849C (en) 2006-10-10
CN1109049C (zh) 2003-05-21
GR3035941T3 (en) 2001-08-31
MX9704824A (es) 1998-06-30
PT814836E (pt) 2001-07-31
CN1175264A (zh) 1998-03-04
BE1008978A5 (fr) 1996-10-01
SI0800539T1 (en) 2003-12-31
PT800539E (pt) 2004-01-30
EP0800539B1 (en) 2003-09-03
DE69531699D1 (de) 2003-10-09
MX9704822A (es) 1998-05-31
JP3927235B2 (ja) 2007-06-06
ATE248863T1 (de) 2003-09-15
AU4324896A (en) 1996-07-19
WO1996020222A1 (en) 1996-07-04
JPH11502192A (ja) 1999-02-23
CN1171052A (zh) 1998-01-21
US6328965B1 (en) 2001-12-11
WO1996020008A1 (fr) 1996-07-04
CA2208790A1 (en) 1996-07-04
AU4324996A (en) 1996-07-19

Similar Documents

Publication Publication Date Title
DK0800539T3 (da) Cyclodekstrinderivater og fremgangsmåder til deres femstilling
ATE410183T1 (de) Verbesserte adjuvant zusammensetzungen auf basis von saponin und damit zusammenhängende methoden
DE122010000041I1 (de) Solubilisierung von capsulären Polysacchariden
NO971622D0 (no) Saponinpreparater og anvendelse derav i immunstimulerende komplekser
NO932102L (no) Oligosakkarid avledet fra antigent polysakkarid erholdt fra et patogen
TR200200774T2 (tr) Aşılar.
NO991524L (no) Vaksiner
DE69529684T2 (de) Adjuvans für impfstoff
PT1104306E (pt) Composicoes de cpg e adjuvantes de saponina e seus metodos
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
DE69739385D1 (de) Verbesserte impfstoffe
ATE419873T1 (de) Synthese von lipopolysaccharid-protein konjugatvaccinen über die lipid-a region nach entfernung des glycosidischen phosphatresidüs
ES2177927T3 (es) Composicion para provocar una reaccion inmunologica a un determinante antigenico no proteinico.
TR200101817T2 (tr) Etkisizleştirilmiş S/Y emülsiyonu katkılı aşılar üretmek için yöntem
DK0547102T3 (da) Opløseliggørelse af proteiner på aktiv form
BG96682A (bg) Метод за получаване на циклохексанови и тетрахидропиранови производни
DE69331459D1 (de) Parenterale immunisierung gegen rotavirus
FI930654A0 (fi) Loesligt aldc-derivat och anvaendning av detta
DK1064294T3 (da) 5-imino-13-deoxyanthracyclin-derivater, deres vendelse og fremgangsmåde til fremstilling af disse
DK1183044T3 (da) Adjuvanskombinationer til immunisering og vacciner
NL300073I1 (nl) Vaccin.
AR011592A1 (es) Metodo de creacion, o mantenimiento o para inducir una inmuno respuesta protectora o adaptativa a un virus hiv en un huesped
ATE220869T1 (de) Möbelfrontelement